Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017


  • Greenwood John
  • Hammarlund-Udenaes Margareta
  • Jones Hazel C.
  • Stitt Alan W.
  • Vandenbroucke Roosmarijn E.
  • Romero Ignacio A.
  • Campbell Matthew
  • Fricker Gert
  • Brodin Birger
  • Manninga Heiko
  • Gaillard Pieter J.
  • Schwaninger Markus
  • Webster Carl
  • Wicher Krzysztof B.
  • Khrestchatisky Michel


  • Animals
  • Humans
  • Blood-Brain Barrier
  • Central Nervous System
  • Neuroinflammation
  • Antibody therapy
  • Blood–brain barrier
  • Blood–CSF barrier
  • Blood–retinal barrier
  • Drug delivery
  • Liposomal technology
  • MicroRNA
  • Nervous System Diseases
  • Protein capsules
  • Viral vectors

document type



This is a report on the CNS barrier congress held in London, UK, March 22-23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers.

more information